14-12-2017 дата публикации
Номер: US20170354616A1
Принадлежит:
A system and method includes delivery of a redox gas solution to treat onychomycosis, wherein the redox gas solution comprises a reactive species dissolved in a perfluorocarbon liquid, and wherein the perfluorocarbon liquid is dispensed onto a gas-permeable membrane and the perfluorocarbon liquid comprises of an anti-inflammatory in a perfluorocarbon liquid and wherein the reactive species may include, alone or in combination, one or more of reactive oxygen, reactive nitrogen, reactive chlorine, or reactive bromine species, and the perfluorocarbon liquid may include perfluorodecalin. 1. A process to prepare an anti-inflammatory perfluorocarbon transfer medium comprising of: placing and anti-inflammatory agent into a glass container of perfluorocarbon liquid and then mixing until the anti-inflammatory agent is suspended in the perfluorocarbon liquid forming a solution , applying said solution to a gas-permeable membrane.2. An anti-inflammatory perfluorocarbon solution of where the anti-inflammatory agent is selected from selected from the group consisting of aspirin claim 1 , Acetylsalicylic acid claim 1 , salicylic acid claim 1 , celecoxib (Celebrex) claim 1 , diclofenac (Cambia claim 1 , Cataflam claim 1 , Voltaren-XR claim 1 , Zipsor claim 1 , Zorvolex) claim 1 , diflunisal (Dolobid—discontinued brand) claim 1 , etodolac (Lodine) claim 1 , ibuprofen (Motrin claim 1 , Advil) claim 1 , Ketorolac tromethamine claim 1 , indomethacin (Indocin) and drugs that meet the definition of NSAIDs.3. An anti-inflammatory perfluorocarbon solution of where the perfluorocarbon liquid is selected from selected from the group consisting of fluoroheptanes claim 1 , fluorocycloheptanes claim 1 , fluoromethylcycloheptanes claim 1 , fluorohexanes claim 1 , fluorocyclohexanes claim 1 , fluoropentanes claim 1 , fluorocyclopentanes claim 1 , fluoromethylcyclopentanes claim 1 , fluorodimethylcyclopentanes claim 1 , fluoromethylcyclobutanes claim 1 , fluorodimethylcyclobutanes claim 1 , ...
Подробнее